Catalyst Flex Videos

  1. How Small Biotechs Can Afford An FSP Model 11/7/2025

    Lois Kelly explains how smaller biopharma companies can make an FSP model work even with limited budgets. She details how she built her own RFPs, compared boutique and large CROs, and emphasized governance, alignment, and relationships over cost alone.

  2. Why Big Pharma Is Shifting Toward FSP Solutions 11/7/2025

    Samir Shah describes how large pharmaceutical companies are moving decisively toward FSP-derived models. He explains how AI investments, cost efficiency, and improved control over operations are driving a lasting structural shift — not a short-term trend — across the industry.

  3. Embedding FSP Teams Into The Company Culture 11/7/2025

    In this segment, Lois Kelly, VP of Research and Clinical Operations at the National Down Syndrome Society, describes how shared holidays, team events, and open communication helped FSP staff feel valued.

  4. FSP Vs. FSO: It's No Longer Binary 11/7/2025

    Samir Shah, Principal at Shaw Pharma Consulting Services, outlines how today’s outsourcing exists on a continuum — where companies mix elements of both models based on their core and critical competencies rather than forcing a one-size-fits-all structure.

  5. Choosing The Right Outsourcing Model Starts With Strategy 11/7/2025

    Before picking an outsourcing model, companies must know what they’re trying to achieve. Jeremy Weitz, Director of Procurement for Global Clinical Services at Biogen, explains how aligning operating models with business strategy leads to better scalability, flexibility, and quality outcomes.

  6. 'Country in a Box' And Other Smart Outsourcing Moves 11/7/2025

    Jeremy Weitz breaks down the “country in a box” approach — a flexible FSP model that lets sponsors operate efficiently in countries where they lack a local footprint.

  7. Prioritizing Safety In Clinical Trials 8/27/2025

    This presentation explores organizational culture and the values that are essential to delivering high-quality safety oversight.

  8. Partnering With Functional Service Providers 8/27/2025

    In this presentation, we share insights into how a culture-forward FSP framework enhances operational efficiency, strengthens partnerships, and helps organizations adapt to growingly complex research.

  9. Discover Operational Excellence 8/27/2025

    Selecting the right functional service provider (FSP) is a critical factor in advancing clinical research programs efficiently, and this reimagined FSP model prioritizes each client’s unique objectives.

  10. An Innovative Approach To Functional Outsourcing 8/27/2025

    The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.